Upgrade to SI Premium - Free Trial

Northwest Biotherapeutics (NWBO)

0.21 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/21/25 *Est.)

Latest Headlines

Form 10-Q NORTHWEST BIOTHERAPEUTIC For: Mar 31 May 15, 2026 4:39 PM - SEC Filing CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities May 11, 2026 8:30 AM - Globe NewsWire Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform April 30, 2026 12:31 PM - PR NewsWire Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic April 21, 2026 9:30 AM - PR NewsWire Form EFFECT NORTHWEST BIOTHERAPEUTIC April 21, 2026 6:05 AM - SEC Filing Form POS AM NORTHWEST BIOTHERAPEUTIC April 16, 2026 5:26 PM - SEC Filing Form 10-K NORTHWEST BIOTHERAPEUTIC For: Dec 31 April 15, 2026 4:17 PM - SEC Filing Form 8-K NORTHWEST BIOTHERAPEUTIC For: Oct 24 April 7, 2026 1:28 PM - SEC Filing Form NT 10-K NORTHWEST BIOTHERAPEUTIC For: Dec 31 March 31, 2026 5:05 PM - SEC Filing Full Article List